Clinical Nurse Specialist in Saint Cloud, MN Accepting Medicare

9 Clinical Nurse Specialist nurses found. Showing 1 - 9

Mary Kaye Weis, CNS Clinical Nurse Specialist Medicare: May Accept Medicare Assignments Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131    Fax: 320-240-2118

Mr. Lance Gregory Westerlund, R.N., R.T. Clinical Nurse Specialist - Chronic Care Medicare: Not Enrolled in Medicare Practice Location: 1511 Northway Dr Ste 101, Saint Cloud, MN 56303 Phone: 320-654-8266    Fax: 320-654-8481

Diane R Spaniol, CNS APRN BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131    Fax: 320-240-2118

Cara Plaine, RN CNS Clinical Nurse Specialist - Psych/Mental Health Medicare: May Accept Medicare Assignments Practice Location: 1900 Centracare Cir, Ste 1000, Saint Cloud, MN 56303 Phone: 320-229-4945    Fax: 320-229-5141

Jill Ann Massmann, DNP, APRN, AGCNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-251-2700

Ms. Robin Lee Johnson, CNS Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Medicare Enrolled Practice Location: 4801 Veterans Dr, Saint Cloud, MN 56303 Phone: 320-252-1670

Shannon Patricia Anderson, APRN CNP Clinical Nurse Specialist - Psych/Mental Health, Child & Adolescent Medicare: Medicare Enrolled Practice Location: 1406 6th Ave N, St Cloud Hospital, Saint Cloud, MN 56303 Phone: 320-251-2700    Fax: 320-656-7115

Mary Elizabeth Kosiba, Clinical Nurse Specialist - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 4801 Veterans Dr, Saint Cloud, MN 56303 Phone: 320-252-1670

Mrs. Renotta Gail Stainbrook, APRN Clinical Nurse Specialist - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4801 Veterans Dr, Mail Routing: 112a, Saint Cloud, MN 56303 Phone: 320-255-6480

News Archive

Synthelis secures initial funding to accelerate commercial development of membrane proteins

Synthelis, a company specializing in the production and characterization of therapeutic targets and antigens, announces today that it has secured initial backing of EUR 610,000 from a group of French investors comprising Rhone-Alpes Creation, Alpes Developpement Durable Investissement (A2D-Invest), Sud Rhone-Alpes Capital, Viaduc and the Savoy and Grenoble Business Angels networks.

Quest PharmaTech, Hemispherx Biopharma enter clinical development arrangement

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced a clinical development arrangement with U.S. based Hemispherx Biopharma Inc. to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Hemispherx's immune activator in a thirty patient clinical trial.

African-Americans fare better in the short term following coronary interventions

Racial disparities in cardiovascular outcomes are well-established, however new findings from University of Pittsburgh researchers indicate that African-Americans fare better in the short term following coronary interventions.

Synergy receives $244,479 grant under QTDP program to develop plecanatide for gastrointestinal disorders

Synergy Pharmaceuticals, Inc. a developer of new drugs to treat gastrointestinal disorders (GI) and diseases, announced today that it has been awarded a $244,479 grant under the Qualifying Therapeutic Discovery Project (QTDP) program to aid the Company in its development of plecanatide currently in clinical development to treat gastrointestinal disorders.

TB Alliance announces start of clinical trial to treat XDR-TB

TB Alliance and its partners announced the start of a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (XDR-TB). It is the first study to test an all-oral drug regimen, comprised of drugs with minimal pre-existing resistance, that has the potential to shorten, simplify, and improve treatment for XDR-TB.

Read more Medical News

› Verified 2 days ago